Report - CENTER FOR DRUG EVALUATION AND RESEARCH...a randomized, double-blind, double-dummy, noninferiority study evaluating the efficacy and safety of administering rivaroxaban 20 mg once

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form